Vertex Pharma (VRTX) Tops Q3 EPS by 30c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
UPDATE: Vertex (VRTX) Initiated at Buy at UBS
October 27, 2020 4:50 PM EDT(Updated - October 27, 2020 5:02 PM EDT)
UBS analyst Colin Bristow starts Vertex (NASDAQ: VRTX) at Buy, PT $287.00
... More
